XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights


You May Also Like

Calithera Biosciences Announces Clinical Data Presentations at ASCO 2016

SOUTH SAN FRANCISCO, Calif., April 21, 2016 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA) ...

Horizon Pharma plc Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

DUBLIN, Ireland, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...